A pulmonary embolism happens when a blood clot travels to your lungs and blocks a blood vessel. This can cause sudden shortness of breath and chest pain. It's a serious condition that needs quick medical attention.
Every report comes from a Lived member, sent anonymously.
Have you tried Eliquis (Apixaban) for Pulmonary Embolism?
A pulmonary embolism (PE) is a sudden blockage in one of the arteries that carry blood through the lungs. It is usually caused by a blood clot that forms in a deep vein, most often in the leg, then breaks loose and travels through the bloodstream until it lodges in the lung. A clot in a deep vein is called a deep vein thrombosis (DVT), and doctors group the two together as venous thromboembolism (VTE), because they are one disease process at different stages. A blocked lung artery keeps part of the blood from picking up oxygen and forces the heart to work harder to push blood through the lungs. Typical symptoms are shortness of breath, fast breathing, chest pain that gets worse with a deep breath or a cough, and a racing heart. Some people cough up blood, feel lightheaded or faint. Symptoms can start within minutes or build over days, and some people notice little at first. A large clot, or many clots, can be life-threatening, which is why a suspected PE is treated as an emergency.
Clots form in deep veins when blood flow slows down, when a vein is damaged, or when the blood clots more easily than usual. Most people who develop a PE have more than one of these influences at once, and the chance rises with each added risk factor. Many of the strongest triggers are temporary: major surgery (especially hip or knee replacement), a broken hip or leg or other serious injury, a hospital stay or bed rest, and long stretches without moving, such as wearing a cast or taking a long flight. After surgery, the risk is highest in the first three months. Longer-lasting risk factors include cancer and its treatment, heart and lung disease, obesity, a previous clot, and inherited clotting tendencies that can run in families. Risk climbs with age, roughly doubling with each decade after 40. Estrogen-containing birth control and menopausal hormone therapy raise the risk, as do pregnancy and especially the six weeks after giving birth. Sometimes a PE happens without any clear trigger, which doctors call unprovoked. Whether a clot was provoked by a temporary cause or not matters later, because it shapes how long treatment lasts. Rarely, something other than a clot blocks the artery, such as fat droplets, an air bubble, amniotic fluid or tumor cells.
PE can be hard to recognize because its symptoms overlap with those of heart attack, pneumonia and other heart and lung problems. A clinician starts with the symptoms, a physical exam and the person's risk factors, and checks the oxygen level in the blood, since a low level can point toward a clot. When the chance of a PE seems low, a D-dimer blood test is often the first step. D-dimer is a protein fragment released as the body breaks down a clot. A normal result in someone at low risk makes a clot unlikely and can spare them a scan. A high result is not proof of a PE, because pregnancy, recent surgery, heart disease, older age and being bedbound can also raise it, so it leads to imaging rather than a diagnosis. The main imaging test is a computed tomography (CT) pulmonary angiogram, a CT scan taken after contrast dye is injected into a vein so the lung arteries and any clots show up. A ventilation-perfusion (V/Q) scan, which compares airflow and blood flow in the lungs, is another way to look for clots. An ultrasound of the legs can find a source clot, and a heart ultrasound (echocardiogram) and an electrocardiogram (ECG) add information about how the heart is coping. How severe the PE is, especially whether blood pressure is holding up, shapes the treatment that follows.
Treatment aims to keep the clot from growing, prevent new clots and protect the heart and lungs while the body gradually breaks down the existing clot. The main treatment is an anticoagulant, commonly called a blood thinner. Despite the name, it does not dissolve the clot; it stops the blood from adding to it and from forming new ones. For most people, guidelines favor a direct oral anticoagulant, a pill such as apixaban (Eliquis) or rivaroxaban (Xarelto), over warfarin. Warfarin, an older pill, is still used in some situations and requires regular blood tests of the international normalized ratio (INR), a measure of how long blood takes to clot, to keep the dose in range. Heparin-type medicines, given by injection or through an IV, are another option. Some blood thinners are not safe to take during pregnancy, so pregnancy changes which one is used. People whose PE is small and whose heart and blood pressure are stable can often be treated at home rather than in hospital. Blood thinners are usually taken for at least three months. When a clot had a clear temporary cause, such as surgery, treatment often stops after that. When there was no clear cause, or the risk factor persists, as with some cancers, longer or indefinite treatment may be recommended. The main trade-off is bleeding, which is usually minor (bruising, nosebleeds, heavier periods) but can be serious, so the length of treatment balances the risk of another clot against the risk of bleeding. For a large PE causing very low blood pressure or shock, doctors may give a thrombolytic, a clot-dissolving medicine given through an IV. It carries a higher risk of sudden, serious bleeding, so it is reserved for life-threatening cases. Another option in selected cases is a catheter procedure, in which a thin tube is threaded to the lung artery to break up or remove the clot or deliver medicine directly. A filter placed in the body's largest vein (an inferior vena cava filter) can catch clots on their way to the lungs in people who cannot take blood thinners, but it does not stop new clots from forming.
PE needs treatment right away, and how well someone recovers depends on the size of the clot, what caused it and their overall health. Recovery is usually gradual: breathlessness, tiredness and reduced stamina can take time to settle, and it can take a year or more for a clot to break up fully and for blood flow to return to normal. Staying active as the care team allows is part of recovery. Daily life on a blood thinner involves taking it exactly as prescribed, making sure every clinician knows about it, and checking before starting other medicines or supplements, since some, including aspirin and other anti-inflammatory pain relievers, add to bleeding risk. People taking warfarin also need regular blood tests and a steady intake of vitamin K, which is found in leafy greens. Follow-up visits review how symptoms are settling and whether blood thinners should continue. Clots can come back: about 1 in 3 people who have had a VTE have another within 10 years. Taking medicine as prescribed, keeping active, managing weight and not smoking all help reduce that chance. Some people develop lasting breathlessness because leftover clot scars the lung arteries and raises the pressure in them, a condition called chronic thromboembolic pulmonary hypertension. It can be treated, in some cases by surgery to remove the remaining clot. Anxiety and fear about another clot are common after a PE, and are worth raising with the care team.
Call 911 or go to the emergency room for sudden shortness of breath, chest pain that worsens with breathing, coughing up blood, or fainting, whether or not you have had a clot before. Contact your care team right away for swelling, pain, warmth or redness in one leg, which can signal a new deep vein clot, and for signs of bleeding on a blood thinner such as easy bruising, bleeding gums, blood in the urine or stool, or unusually heavy periods. Heavy bleeding that will not stop is an emergency. Arrange a visit if breathlessness or reduced stamina has not improved several months after a PE, if you are planning surgery, pregnancy or a change in hormone treatment while on a blood thinner, or if you want to review whether to continue treatment.
Last reviewed • Oct 2026
Educational content, not medical advice.